Free Republic

An unlicensed intravenous form of the antiviral drug Relenza saved the life of a woman with a severe illness resulting from infection by the pandemic H1N1 influenza virus, British doctors reported today in the journal Lancet. Dr. Michael Kidd and Dr. Mervyn Singer of the University College London Hospitals were treating the virus, commonly known as swine flu, in a 22-year-old woman who had contracted it after undergoing chemotherapy for Hodgkin's disease. The woman had increasing shortness of breath, build-up of fluid in both lungs and was progressively deteriorating. Physicians had given her Tamiflu and Relenza, which is normally given...

Associated Press Government health regulators recommended adding label precautions about neurological problems seen in children who have taken flu drugs made by Roche and GlaxoSmithKline. The Food and Drug Administration on Friday released its safety review of Roche's Tamiflu and Glaxo's Relenza. Next week, an outside group of pediatric experts is scheduled to review the safety of several such drugs when used in children. FDA began reviewing Tamiflu's safety in 2005 after receiving reports of children experiencing neurological problems, including hallucinations and convulsions. Twenty-five patients under age 21 have died while taking the drug, most of them in Japan. Five...

AP MEDICAL WRITER WASHINGTON -- Mass production of a new vaccine that promises to protect against bird flu is poised to begin, as the government on Thursday agreed to stockpile $100 million worth of inoculations. The new contract with French vaccine maker Sanofi-Pasteur marks a major scale-up in U.S. preparation for the possibility that the worrisome virus could spark an influenza pandemic. While the vaccine is still experimental, preliminary results from the National Institutes of Health's first testing in people suggest the inoculations spur an immune response that would be strong enough to protect against known strains of the avian...